Myriam Armant

5PUBLICATIONS
47CO-AUTHORS
Molecular targetsChemical engineering designRegenerative medicine (incl. stem cells)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 26, 2026
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

|Mar 04, 2025
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US.

Ula V Jurkunas, Aaron R Kaufman, Jia Yin

|Nov 17, 2023
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.

Michael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu

|Sep 20, 2023
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.

Daniel C De Souza, Nicolas Hebert, Erica B Esrick

|Dec 15, 2022
Human genetic diversity alters off-target outcomes of therapeutic gene editing.

Samuele Cancellieri, Jing Zeng, Linda Yingqi Lin

Pageof 1

Frequent Collaborators

1 joint publications

Samuele Cancellieri

1 joint publications

Linda Yingqi Lin

1 joint publications

Manuel Tognon

1 joint publications

Shengdar Q Tsai